Cargando…
The juvenile gangliosidoses: A timeline of clinical change
BACKGROUND: The gangliosidoses are rare inherited diseases that result in pathologic accumulation of gangliosides in the central nervous system and other tissues, leading to severe and progressive neurological impairment and early death in the childhood forms. No treatments are currently approved fo...
Autores principales: | King, Kelly E., Kim, Sarah, Whitley, Chester B., Jarnes-Utz, Jeanine R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674119/ https://www.ncbi.nlm.nih.gov/pubmed/33240792 http://dx.doi.org/10.1016/j.ymgmr.2020.100676 |
Ejemplares similares
-
Chitotriosidase as a biomarker for gangliosidoses
por: Kim, Sarah, et al.
Publicado: (2021) -
Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study
por: Nestrasil, Igor, et al.
Publicado: (2017) -
Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling
por: Ou, Li, et al.
Publicado: (2019) -
Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report(,)
por: Kim, Sarah, et al.
Publicado: (2017) -
Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016)